His suggested timeline for green-lighting psychedelic therapy surprised even the most bullish supporters of the drugs.

A new study published in the Journal of Psychopharmacology has found that MDMA’s mood-enhancing effects may be partly driven by changes in brain systems related to serotonin, oxytocin, and vasopressin ...

Australia’s largest health insurance company, Medibank Private Ltd., is the first to reimburse for psychedelic treatment in Australia, funding Emyria Ltd.’s MDMA (3,4-methylenedioxy-methamphetamine) ...

America rejected MDMA, but Australia didn’t. Here’s why psychedelics have been embraced Down Under Australia recently became the first country to legalize both MDMA and psilocybin-assisted ...

Psychedelic pioneer is unfazed about MDMA’s prospects, despite FDA setback Rick Doblin has plans to continue fighting to get MDMA — also known as ecstasy — accepted by the medical establishment.

We were this close to seeing Ecstasy being incorporated into therapy in the US in 2024. Now, we have to wait either a little or a lot – depending on how the chips fall. Let's have a closer look ...

First came the rejection, and then came the retractions. On Friday, in a decision that would have been stunning just six months ago, the Food and Drug Administration decided against approving MDMA ...

The US Food and Drug Administration has declined to approve an application for the use of MDMA, commonly known as ecstasy, as a treatment for post-traumatic stress disorder, according to a news ...

Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen for treating PTSD. It says another study will take "several years." ...

The FDA rejected an application for the drug MDMA, in combination with therapy, as treatment for PTSD on Friday.